Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 578787Generated: November 2, 2026

Iodobenzene → HCID 68997712, compound

https://huagongshe.com/reaction/578787

Reaction equation

Participants

RoleNameHCIDCharge
ReactantIodobenzeneHCID 11575—
ReactantHCID 58022178HCID 58022178—
CatalystCopper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)HCID 24350—
SolventDiisopropylamineHCID 7912—
SolventEthyl AcetateHCID 8857—
ProductHCID 68997712HCID 6899771296.2%

Reaction Steps

A mixture of 1-(tert-butoxycarbonylamino)-5-ethynyl -2-fluorobenzene (0.11 g), iodobenzene (0.1 g), tetrakis -(triphenylphosphine)palladium(0) (16 mg) and copper (I) iodide (5 mg) in N,N-diisopropylamine (2 mL) was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate. The insoluble material was removed by filtration, and the filtrate was concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (eluent: n-hexane/ethyl acetate=10/1) to give 1-(tert -butoxycarbonylamino)-2-fluoro-5-phenylethynylbenzene (0.14 g). This material was dissolved in ethyl acetate (3 mL). To the solution was added 10% palladium-carbon powder (50 mg), and the mixture was stirred at room temperature under a hydrogen atmosphere for 2 hours. The insoluble material was removed by filtration, and the filtrate was concentrated under reduced pressure to give 1-(tert-butoxycarbonylamino)-2-fluoro -5-(2-phenylethyl)benzene (0.11 g). To this material was added hydrochloric acid (4 mol/L ethyl acetate solution, 3 mL), and the mixture was stirred at room temperature for 1 hour. The reaction mixture was poured into a saturated aqueous sodium hydrogen carbonate solution, and the resulting mixture was extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure. The residue was purified by column chromatography on silica gel (eluent: n-hexane/ethyl acetate =8/1 -5/1) to give the title compound (53 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09040693B2
Source datasetuspto-grants-2015_05
ORD IDord-7db41d83a0c348b9aac6ca459f274cc0
Source noteuspto-grants-2015_05